Ann Dermatol.  2015 Jun;27(3):334-335. 10.5021/ad.2015.27.3.334.

Bupropion-Induced Erythema Multiforme

• Evrensel A
• Ceylan ME

• KMID: 2352511
• DOI: http://doi.org/10.5021/ad.2015.27.3.334

Abstract

No abstract available.

MeSH Terms

Erythema Multiforme*

Figure

• 

  Fig. 1 Two, 2~3 cm, vesicular lesions on the right forearm.

• 

  Fig. 2 Skin lesions after the termination of the bupropion treatment.

Reference

1. Mitkov MV, Trowbridge RM, Lockshin BN, Caplan JP. Dermatologic side effects of psychotropic medications. Psychosomatics. 2014; 55:1–20.

2. Preskorn SH. Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry. 1995; 56:Suppl 6. 12–21.

3. Stahl SM, Pradko JF, Haight BR, Modell JG, Rockett CB, Learned-Coughlin S. A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry. 2004; 6:159–166.

4. Lineberry TW, Peters GE Jr, Bostwick JM. Bupropioninduced erythema multiforme. Mayo Clin Proc. 2001; 76:664–666.

5. Carrillo-Jimenez R, Zogby M, Treadwell TL. Erythema multiforme associated with bupropion use. Arch Intern Med. 2001; 161:1556.